Genetics
-
Every gene of deadliest malaria parasite identified
US scientists have analysed every gene in the most deadly malaria parasite for the first time to help identify and prioritise new drug targets, it was revealed last night (3 May 2018). Read more
-
Carboplatin effective when BRCA gene present
Women with advanced ‘triple-negative’ breast cancer and BRCA gene mutations respond better to the chemotherapy drug carboplatin than standard treatment, according to the findings of a major clinical trial published last night. Read more
-
NAT10 defence for genetic disease?
A potential target has been identified that could benefit sufferers of a rare genetic disease that causes premature ageing. Read more
-
Gene insight into malaria
Researchers have gained new insights into the genes linked to risk of malaria, it was announced today on World Malaria Day. Read more
-
NHS genomics project “at risk” – MPs
Ambitious plans to make the NHS a world leader in genomics are at risk, MPs warn today. Read more
-
Challenge to find treatable cancer mutations
Oncologists face a huge task to identify which of thousands of recently identified genetic mutations in cancer are worth targeting with drug treatments, European experts have warned. Read more
-
New growth hormone deficiency test
Researchers in Manchester are hoping to develop an improved test for growth hormone deficiency in children using machine learning and DNA analysis. Read more
-
Muscle mutation linked to SIDS
A rare genetic mutation affecting the muscles controlling the lungs may be responsible for some cases of sudden infant death syndrome, researchers report today. Read more
-
Dilated cardiomyopathy investigated
A new study has been launched to investigate the interaction between genes and lifestyle factors in the development of dilated cardiomyopathy. Read more
-
Osteoarthritis genes revealed
British researchers have identified nine new genes implicated in osteoarthritis, it was announced last night. Read more
